DGX

236.25

0.31% 0.73

Dopo l'orario di chiusura: 236.25

Quest Diagnostics Inc (DGX)

Panoramica Notizia Cronologia dei prezzi Catena di opzioni Financials Forum Previsione Frazionamento azionario Storia dei dividendi

Precedente Chiudi:

$235.52

Aprire:

$238.01

Volume 24 ore:

693.60K

Relative Volume:

0.77

Capitalizzazione di mercato:

$26.08B

Reddito:

$11.28B

Utile/perdita netta:

$1.07B

Rapporto P/E:

26.06

EPS:

9.0657

Flusso di cassa netto:

$1.33B

1 W Prestazione:

-0.53%

1M Prestazione:

+12.14%

6M Prestazione:

+15.59%

1 anno Prestazione:

+32.02%

Intervallo 1D:

$236.07

$239.38

Intervallo di 1 settimana:

$232.28

$240.00

Portata 52W:

$171.18

$240.13

Quest Diagnostics Inc Stock (DGX) Company Profile

Nome

Quest Diagnostics Inc

Settore

Healthcare (1072)

Industria

Diagnostics & Research (49)

Telefono

(973) 520-2700

Indirizzo

500 PLAZA DRIVE, SECAUCUS

Dipendente

57,000

Cinguettio

@QuestDX

Prossima data di guadagno

2026-07-23

Ultimi documenti SEC

DGX's Discussions on Twitter

Compare DGX vs TMO, DHR, NTRA, IDXX, A

Azioni	Prezzo	Cap. di mercato	Reddito	Reddito netto	Flusso di cassa	EPS
DGX Quest Diagnostics Inc	236.25	26.00B	11.28B	1.07B	1.33B	9.0657
TMO Thermo Fisher Scientific Inc	589.04	216.49B	45.20B	6.87B	6.75B	18.19
DHR Danaher Corp	199.58	142.45B	24.78B	3.68B	5.29B	5.1743
NTRA Natera Inc	311.69	45.29B	2.50B	-226.32M	71.51M	-1.6412
IDXX Idexx Laboratories Inc	553.32	43.02B	4.45B	1.10B	1.06B	13.59
A Agilent Technologies Inc	148.44	41.93B	7.23B	1.41B	1.09B	4.979

Quest Diagnostics Inc Stock (DGX) Upgrades & Downgrades

Data	Azione	Analista	Modifica della valutazione
2026-01-30	Aggiornamento	Barclays	Equal Weight → Overweight
2025-08-25	Downgrade	Robert W. Baird	Outperform → Neutral
2025-04-02	Iniziato	Redburn Atlantic	Buy
2025-03-04	Downgrade	Citigroup	Buy → Neutral
2025-01-06	Aggiornamento	Leerink Partners	Market Perform → Outperform
2024-12-17	Aggiornamento	Morgan Stanley	Equal-Weight → Overweight
2024-12-10	Ripresa	Jefferies	Buy
2024-10-23	Aggiornamento	Robert W. Baird	Neutral → Outperform
2024-08-28	Ripresa	Evercore ISI	In-line
2024-07-10	Aggiornamento	Citigroup	Neutral → Buy
2024-02-26	Iniziato	Leerink Partners	Market Perform
2024-02-07	Aggiornamento	Jefferies	Hold → Buy
2024-01-03	Iniziato	Barclays	Equal Weight
2023-12-12	Aggiornamento	BofA Securities	Neutral → Buy
2023-06-29	Iniziato	Piper Sandler	Neutral
2023-05-02	Downgrade	BofA Securities	Buy → Neutral
2023-04-03	Aggiornamento	Citigroup	Sell → Neutral
2023-01-23	Iniziato	Evercore ISI	In-line
2022-11-17	Downgrade	Citigroup	Neutral → Sell
2022-08-22	Ripresa	Morgan Stanley	Equal-Weight
2022-04-04	Downgrade	Citigroup	Buy → Neutral
2022-02-23	Downgrade	UBS	Buy → Neutral
2022-02-02	Downgrade	Jefferies	Buy → Hold
2022-01-28	Downgrade	Deutsche Bank	Buy → Hold
2021-05-04	Aggiornamento	UBS	Neutral → Buy
2021-03-12	Downgrade	Robert W. Baird	Outperform → Neutral
2020-10-21	Aggiornamento	Argus	Hold → Buy
2020-07-29	Aggiornamento	KeyBanc Capital Markets	Sector Weight → Overweight
2020-07-14	Aggiornamento	BofA Securities	Neutral → Buy
2020-06-09	Aggiornamento	Wells Fargo	Underweight → Equal Weight
2020-06-02	Aggiornamento	Deutsche Bank	Hold → Buy
2020-04-28	Aggiornamento	Morgan Stanley	Equal-Weight → Overweight
2020-04-27	Aggiornamento	Citigroup	Neutral → Buy
2020-04-27	Aggiornamento	Wolfe Research	Underperform → Peer Perform
2020-03-27	Downgrade	Morgan Stanley	Overweight → Equal-Weight
2020-01-08	Iniziato	Wells Fargo	Underweight
2020-01-07	Downgrade	Barclays	Overweight → Equal Weight
2019-12-19	Aggiornamento	BofA/Merrill	Underperform → Neutral
2019-07-15	Downgrade	Goldman	Neutral → Sell
2019-04-02	Aggiornamento	Jefferies	Hold → Buy
2019-03-18	Ripresa	Credit Suisse	Neutral
2019-01-31	Downgrade	Argus	Buy → Hold
2019-01-17	Iniziato	UBS	Neutral
2019-01-03	Downgrade	BofA/Merrill	Neutral → Underperform
2018-12-03	Downgrade	BofA/Merrill	Buy → Neutral
2018-11-30	Downgrade	Goldman	Buy → Neutral

Mostra tutto

Quest Diagnostics Inc Borsa (DGX) Ultime notizie

Aug 18, 2026

Quest Diagnostics (DGX) Upgraded to Buy: Here's Why - Yahoo Finance

Aug 18, 2026

WHOOP opens blood tests to nonmembers and adds a test for signals tied to 50+ cancer types - Stock Titan

Aug 18, 2026

Nuance Investments LLC Takes Position in Quest Diagnostics Incorporated $DGX - marketbeat.com

Aug 18, 2026

Occidental Asset Management LLC Invests $6.12 Million in Quest Diagnostics Incorporated $DGX - marketbeat.com

Aug 18, 2026

Cornerstone Advisors LLC Invests $10.01 Million in Quest Diagnostics Incorporated $DGX - marketbeat.com

Aug 18, 2026

GSA Capital Partners LLP Purchases Shares of 4,971 Quest Diagnostics Incorporated $DGX - marketbeat.com

Aug 18, 2026

Quest Diagnostics (NYSE:DGX) Shows Dividend Quality Beyond the Headline Yield - ChartMill

Aug 18, 2026

Aug 17, 2026

Simplicity Wealth LLC Acquires New Position in Quest Diagnostics Incorporated $DGX - marketbeat.com

Aug 17, 2026

J.Safra Asset Management Corp Purchases New Shares in Quest Diagnostics Incorporated $DGX - marketbeat.com

Aug 17, 2026

Aug 16, 2026

ABN AMRO Bank N.V. Takes $21.52 Million Position in Quest Diagnostics Incorporated $DGX - marketbeat.com

Aug 16, 2026

Aug 15, 2026

Carol Devine Miller sells stocks in Pfizer, Quest Diagnostics, Target, and U.S. Bancorp - Investing.com South Africa

Aug 15, 2026

Aug 14, 2026

Quest Diagnostics (DGX) Is Up 2.29% in One Week: What You Should Know - Yahoo Finance

Aug 14, 2026

T. Rowe Price Associates (DGX) discloses 5.43M Quest Diagnostics shares in 13G/A - Stock Titan

Aug 14, 2026

Assenagon Asset Management S.A. Acquires 4,334 Shares of Quest Diagnostics Incorporated $DGX - MarketBeat

Aug 14, 2026

Aug 13, 2026

Quest Diagnostics Incorporated (NYSE:DGX) Plans Quarterly Dividend of $0.86 - MarketBeat

Aug 13, 2026